RNAi Candidate in Development for Coronavirus

May 13, 2020

RNAi Candidate in Development for Coronavirus

Alnylam and Vir Biotechnology are working on an anti-SARS-CoV-2 inhaled RNAi candidate, which is expected to begin in-human testing by the end of the year. Yourway is equipped to handle all clinical trials, including our ongoing direct-to-patient services.

Back to Index

Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Global Clinical Supplies Group (GCSG)

October 14-16, 2025
Hungary, Budapest

Schedule a Meeting

Clinical Outsourcing Group (COG)

October 21-22, 2025
Burlingame, California

Schedule a Meeting

Media

Articles

Keeping trials on track: Prioritizing communication in decentralized trials

Open chat

Hello! How can I help you?